We at The KIS Foundation, Inc., are simply ecstatic to celebrate the U.S. Food and Drug Administration’s approval of Endari®. This marks the FIRST NEW LIFE-CHANGING TREATMENT for Sickle Cell Disease in almost 20 years! It’s also the first-ever treatment approved for children.
We salute the research and medical advancements of LA BioMed and Emmaus Life Sciences of Torrance for developing this noninvasive medical treatment for #SCD patients!!